SAM
GILD icon

Sherman Asset Management’s Gilead Sciences GILD Stock Holding History

Sherman Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Sell
1,523
-397
-21% -$52.3K 0.15% 55
2026
Q1 		$268K Hold
1,920
– – 0.25% 42
2025
Q4 		$236K Hold
1,920
– – 0.2% 50
2025
Q3 		$213K Hold
1,920
– – 0.18% 52
2025
Q2 		$213K Hold
1,920
– – 0.19% 54
2025
Q1 		$215K Sell
1,920
-11
-0.6% -$1.14K 0.21% 54
2024
Q4 		$178K Buy
+1,931
New +$174K 0.16% 62

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sherman Asset Management's GILD Position: Q2 2026 in Review

Sherman Asset Management reduced its Gilead Sciences (GILD) stake by 21% in Q2 2026, selling an estimated $52.3K and leaving 1,523 shares worth $192K. The position accounts for 0.15% of the portfolio, ranked #55.

Sherman Asset Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $268K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sherman Asset Management held 1,523 shares of Gilead Sciences worth $192K as of Q2 2026.
  • Sherman Asset Management sold 397 Gilead Sciences shares in Q2 2026, an estimated $52.3K.
  • Gilead Sciences made up 0.15% of Sherman Asset Management's portfolio in Q2 2026, its #55 holding.
  • Sherman Asset Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Sherman Asset Management's Gilead Sciences position peaked at $268K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sherman Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.